International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8098539
Original Article
Serum Levels of Vitamin D in Patients of Diabetic Retinopathy at a Tertiary Level in North India
 ,
 ,
 ,
 ,
Published
June 30, 2023
Abstract

Introduction: Diabetic retinopathy is a major complication of diabetes mellitus that can result in retinal vascular abnormalities and severe visual impairment. Vitamin D deficiency is involved in impaired glucose tolerance or type-2 diabetes. Vitamin D may affect the pathogenesis of diabetic retinopathy via its effects on angiogenesis by changing the presence of hypoxia inducible products, such as vascular endothelial growth factor.

Study design: It was cross-sectional study done at a tertiary centre in North India.

Results: In the Non proliferative diabetic retinopathy, proliferative diabetic retinopathy, diabetics without retinopathy and healthy controls mean serum vitamin D levels were  22.36 ± 4.90 ng/ml, 21.03 ± 6.21ng/ml, 26.44 ± 4.98 mg/dl 35.80 ± 5.20 ng/ml respectively.

Conclusion: The serum vitamin D levels were lower in Type 2 diabetic patients as compared to Healthy controls. The serum vitamin D levels were lower in diabetic patients with retinopathy as compared to diabetic patients without retinopathy. The serum vitamin D levels were slightly lower in Proliferative diabetic retinopathy patients as compared to Non proliferative diabetic retinopathy patients.

Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2286 Views
438 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved